Take action initiates enrollment in TEMPASURE cardiac ablation catheter CE Mark clinical trial Advanced Cardiac Therapeutics, Inc prescription medicine . The TEMPASURE system is the world’s 1st RF cardiac ablation catheter to provide both saline irrigation and temperature-sensing technology. The system’s novel passive sensing microwave radiometry technology allows the electrophysiologist to measure the temperatures of cardiac tissue at three millimeters depth through the ablation procedure, offering real-time information that allows appropriate energy lesion and delivery control. ‘ACT’s novel catheter system directly measures lesion creation through temperature, addressing a longstanding problem for physicians executing irrigated cardiac ablation,’ stated Karl-Heinz Kuck, M.D., head of the Division of Cardiology, St Georg Hospital, Germany, who is co-principal investigator of the trial.
ACS to provide therapy related teaching and assessment solutions to UCP Ancillary Treatment Solutions , the nationwide leader in assisting healthcare agencies establish and manage physical and occupational therapy applications, today announced it was chosen to provide therapy related assessment and training providers to United Cerebral Palsy of Central Arizona, a non-profit health insurance and human service organization which has served adults and kids with disabilities since 1952. ‘We are confident our expertise in therapy program management can help UCP to reach new levels of operational success and achieve its medical and financial goals.’ ACS leverages its financial, regulatory and operational expertise to greatly help healthcare institutions manage their therapy applications, which range from the development and management of new programs to the growth of existing applications and reinvigoration of underperforming applications..